Zoetis | ZTS - Selling And Administration Expenses



Zoetis reported $617M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
AbbVie USD 3.25B 40M Jun/2025
Align Technology USD 448.69M 1.06M Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Bristol-Myers Squibb USD 1.71B 129M Jun/2025
Charles River Laboratories USD 185.82M 8.02M Jun/2025
Dentsply International USD 334M 23M Jun/2025
Eli Lilly USD 2.75B 390.8M Jun/2025
Henry Schein USD 778M 42M Jun/2025
Idexx Laboratories USD 259.79M 12M Jun/2025
Illumina USD 234M 13M Jun/2025
IQVIA Holdings USD 509M 1000K Jun/2025
J&J USD 5.89B 777M Jun/2025
Laboratory Of America USD 579.3M 33.3M Jun/2025
Merck USD 2.63B 104M Jun/2025
Neogen USD 99.8M 22.72M May/2025
Pacira USD 77.19M 9.58M Jun/2025
Perrigo USD 273.1M 8.1M Jun/2025
Pfizer USD 3.42B 406M Jun/2025
Quest Diagnostics USD 486M 10M Jun/2025
Sanofi EUR 2.63B 408M Jun/2025
Sanofi EUR 2.32B 1.08B Jun/2025
Zoetis USD 617M 54M Jun/2025